埃塞俄比亚轮状病毒疫苗引入对5岁以下儿童胃肠炎住院及毒株基因型的影响(2011-2016)
在埃塞俄比亚3家医院对5岁以下腹泻儿童开展2011-2017年哨点监测,比较疫苗引入前后轮状病毒相关急性腹泻住院比例及毒株基因型。疫苗引入后轮状病毒相关住院比例从24%降至20%,<12月龄儿童从33%降至27%,流行季高峰减弱,流行株基因型多样。
要点
- 疫苗引入后5岁以下儿童轮状病毒相关腹泻住院比例由24%降至20%。
- <12月龄儿童轮状病毒相关住院比例由33%降至27%,降幅最明显。
- 疫苗引入前后流行轮状病毒株基因型多样,以G12P[8]、G2P[4]、G9P[8]、G3P[6]、G3P[8]等为主。
核心结论
- 埃塞俄比亚引入轮状病毒疫苗后,各年龄组轮状病毒相关住院均减少,<12月龄儿童负担最重且降幅最明显。
- 疫苗引入前后流行多种轮状病毒株基因型。
研究设计与样本
- 2011-2017年在埃塞俄比亚亚的斯亚贝巴3家医院对5岁以下腹泻儿童开展哨点监测。
- 粪便标本用抗原捕获酶免疫法检测,轮状病毒阳性样本(疫苗前156份、疫苗后141份)进一步基因分型。
- 疫苗前(2011年7月-2013年6月)入组788名儿童,疫苗后(2014年7月-2017年6月)入组815名儿童。
主要发现
- 5岁以下儿童轮状病毒相关腹泻住院比例从疫苗前24%(188/788)降至疫苗后20%。
- <12月龄儿童轮状病毒相关腹泻住院比例从疫苗前33%降至疫苗后27%。
- 疫苗引入后轮状病毒季节性高峰减弱。
- 流行株:2011年G12P[8](36%),2012年G12P[8](27%),2013年G2P[4](35%),2014年G9P[8](19%),2015年G3P[6]和G2P[4]各19%,2016年G3P[8](29%)。
关键数值与推荐
- 5岁以下儿童轮状病毒相关腹泻住院比例:疫苗前24%(188/788) vs 疫苗后20%。
- <12月龄儿童轮状病毒相关腹泻住院比例:疫苗前33% vs 疫苗后27%。
临床怎么用
- 监测数据显示疫苗引入后轮状病毒相关住院比例下降,<12月龄儿童降幅更明显。
- 疫苗引入前后流行株基因型多样,持续基因型监测可了解流行株变化。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: A monovalent rotavirus vaccine was introduced in the Ethiopian Expanded Program on Immunization from November 2013. We compared impact of rotavirus vaccine introduction on rotavirus associated acute diarrhea hospitalizations and genotypic characteristics of rotavirus strains pre-and post-vaccine introduction. METHODS: Sentinel surveillance for diarrhea among children <5 years of age was conducted at 3 hospitals in Addis Ababa, Ethiopia from 2011 to 2017. Stool specimens were collected from enrolled children and tested using an antigen capture enzyme immunoassay. Rotavirus positive samples (156 from pre- and 141 from post-vaccination periods) were further characterized by rotavirus genotyping methods to identify the predominant G and P types circulating during the surveillance era. RESULTS: A total of 788 children were enrolled during the pre- (July 2011-June 2013) and 815 children during the post-vaccination (July 2014-June 2017) periods. The proportion of diarrhea hospitalizations due to rotavirus among children <5 years of age declined by 17% from 24% (188/788) in the pre-vaccine period and to 20% (161/185) in post-vaccine introduction era. Similarly, a reduction of 18% in proportion of diarrhea hospitalizations due to rotavirus in children <12 months of age in the post (27%) vs pre-vaccine (33%) periods was observed. Seasonal peaks of rotavirus declined following rotavirus vaccine introduction. The most prevalent circulating strains were G12P[8] in 2011 (36%) and in 2012 (27%), G2P[4] (35%) in 2013, G9P[8] (19%) in 2014, G3P[6] and G2P[4] (19% each) in 2015, and G3P[8] (29%) in 2016. DISCUSSION: Following rotavirus vaccine introduction in Ethiopia, a reduction in rotavirus associated hospitalizations was seen in all age groups with the greatest burden in children <12 months of age. A wide variety of rotavirus strains circulated in the pre- and post-vaccine introduction periods.
引用
- Abebe A, Getahun M, Mapaseka SL, et al. Impact of rotavirus vaccine introduction and genotypic characteristics of rotavirus strains in children less than 5 years of age with gastroenteritis in Ethiopia: 2011-2016. Vaccine. 2018. PMID: 30301641. doi:10.1016/j.vaccine.2018.09.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。